SEC Form 4 · accession 0001209191-19-017525
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter M Hecht
Officer — Chief Executive Officer · Director
Period of report
Mar 5, 2019
Accepted (ET)
Mar 6, 2019 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Mar 5, 2019 | G | 2,500,000 | $0.00 | D | 2,217,366 | D | |
| Class A Common StockF2 | holding | — | — | — | 4,850 | I | The 2000 Trust for Alexis Mae Hecht | |
| Class A Common StockF2 | holding | — | — | — | 4,850 | I | The 2000 Trust for Malcolm Paul Hecht | |
| Class A Common StockF2 | holding | — | — | — | 4,850 | I | The 2000 Trust for Zoe Niovi Hecht |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On March 5, 2019, Peter M. Hecht donated the shares of common stock of Ironwood Pharmaceuticals, Inc. to a donor advised fund.
- F2These shares are held in the referenced trust for the benefit of the reporting person's child. The reporting person's spouse is the trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or any other purpose.